3-177038112-C-T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_024665.7(TBL1XR1):c.1108G>A(p.Asp370Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D370Y) has been classified as Pathogenic.
Frequency
Consequence
NM_024665.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBL1XR1 | NM_024665.7 | c.1108G>A | p.Asp370Asn | missense_variant | 12/16 | ENST00000457928.7 | NP_078941.2 | |
TBL1XR1-AS1 | NR_174966.1 | n.341-250C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBL1XR1 | ENST00000457928.7 | c.1108G>A | p.Asp370Asn | missense_variant | 12/16 | 1 | NM_024665.7 | ENSP00000413251 | P1 | |
TBL1XR1-AS1 | ENST00000617758.1 | n.341-250C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | TBL1XR1: PM2, PM5, PP2, PP3, PS4:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 01, 2017 | The D370N pathogenic variant in the TBL1XR1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The D370N variant was not observed in approximately 6000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D370N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. A missense variant in the same residue (D370Y) has been reported in a nonverbal female with global developmental delay (Laskowski et al., 2016), supporting the functional importance of this region of the protein. We interpret D370N as a pathogenic variant. - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2019 | - - |
Pierpont syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | School of Pediatrics, Henan University of Chinese Medicine, Henan University Of Chinese Medicine | - | - - |
Intellectual disability Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Diagnostic Laboratory, Strasbourg University Hospital | Sep 10, 2020 | - - |
Intellectual disability, autosomal dominant 41 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Feb 23, 2023 | PS4_Moderate, PM2, PM5_Supporting, PM6_Strong, PP2, PP3 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at